North American AED Database

The following information was compiled by the Clinical Neuropharmacology Task Force to provide physicians, pharmacists and nurses a reference tool for daily practice. The following information includes anti-epileptic drugs currently in use in North America. Many thanks to the Task Force members for their work.

For more information on drug adverse reactions go to the FDA reporting site at http://www.fda.gov/medwatch/index.html

Disclaimer: While the information provided in this website is believed to be true and accurate at the date of publication, neither the authors nor the AES can accept any legal responsibility for any error or omissions that may be made. The AES as publisher, makes no warranty, express or implied, with respect to the material contained herein. Selected references are provided at the end of each drug for clinical indications, adverse effects and other relevant references.

I have carefully read the above disclaimer.  By clicking the check box, I certify that I understand the disclaimer and agree with it's contents.  I further hold AES harmless from any damage resulting from my use of, or the relaying of, the information contained herein.

Generic Trade
Carbamazepine Tegretol
  Tegretol XR
  Carbatrol
Clonazepam Klonopin
Diazepam Valium
  Diastat
  Diazepam Intesol
Diazepam emulsion Dizac
Ethosuximide Zarontin
Felbamate Felbatol
Fosphenytoin Cerebyx
Gabapentin Neurontin
Lamotrigine Lamictal
Levetiracetam Keppra
Oxcarbazepine Trileptal
Phenobarbital Phenobarbital
Phenytoin Dilantin
Primidone Mysoline
Tiagabine Gabitril
Topiramate Topamax
Valproate, valproic acid, divalproex sodium Depakene
  Depakote
  Depacon
  Depakote ER
Vigabatrin Sabril
Zonisamide Zonegran